MedTrace Logo

Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia

NCT04657809 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-10-26

No results posted yet for this study

Summary

The study aimed to investigate the efficacy of insulin in a new dosage form ( fast dissolving film) in treatment of anosmia in patients post infested with Covid-19. The study implication based in two methods evaluations

1. Threshold test
2. identification test.

Conditions

  • Anosmia

Interventions

COMBINATION_PRODUCT

Insulin film

Insulin suspension vials

DEVICE

Fast dissolving film

Fast dissolving film

Sponsors & Collaborators

  • Minia University

    collaborator OTHER

  • Soad Ali

    lead OTHER

Principal Investigators

  • Soad Mohamed · Deraya

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-02-18
Completion
2021-03-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657809 on ClinicalTrials.gov